论文部分内容阅读
本文报告调免素治疗消化系统及内科其它系统疾病319例的临床疗效与机体免疫功能变化,与对照组60例,分析、探讨了调免素的临床应用价值。两组病人治疗后总有效率分别为84.0％和63.68％(P<0.05)。调免素治疗组细胞免疫功能有明显改变(P<0.01),对照组不明显。调免素在临床上使用是安全的。
This article reports the clinical efficacy and immune function changes of 319 cases of digestive system and other medical diseases in the treatment of digestive system and 60 cases of the control group. The clinical application value of the immunomodulatory hormone was analyzed and discussed. The total effective rates of the two groups after treatment were 84.0% and 63.68% (P <0.05). Immunomodulatory function in the treatment group was significantly changed (P <0.01), while the control group was not obvious. It is safe to use the immunomodulatory drugs clinically.